The following monoclonal antibodies have been added to the interaction checker:
- Belantamab mafodotin - Cancer Therapies
- Belimumab - Immunosuppressants
- Bezlotoxumab - Antibacterials
- Bimekizumab - Immunosuppressants
- Brolucizumab - Other
- Caplacizumab - Anticoagulant, Anti-platelet and Fibrinolytic
- Cemiplimab - Cancer Therapies
- Crizanlizumab - Other
- Dinutuximab beta - Cancer Therapies
- Durvalumab - Cancer Therapies
- Elotuzumab - Cancer Therapies
- Erenumab - Antimigraine Agents
- Fremanezumab - Antimigraine Agents
More monoclonals will be added in due course.
